Y. Tsukamoto et al., Expression of a novel RNA-splicing factor, RA301/Tra2 beta, in vascular lesions and its role in smooth muscle cell proliferation, AM J PATH, 158(5), 2001, pp. 1685-1694
Citations number
40
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
RA301/Tra2 beta, a sequence-specific RNA-binding protein, was first cloned
as a stress molecule in re-oxygenated astrocytes. In human vascular tissues
, we have found enhanced RA301/Tra2 beta expression in coronary artery with
intimal thickening, and atherosclerotic aorta. Balloon injury to the rat c
arotid artery induced RA301/Tra2 beta transcripts followed by expression of
the antigen, which was detected in medial and neointimal vascular smooth m
uscle cells (VSMCs). In cultured VSMCs, hypoxia/re-oxygenation caused induc
tion of RA301/Tra2 beta and was accompanied by cell proliferation, both of
which were blocked by the addition of either diphenyl iodonium, a NADPH oxi
dase inhibitor, PD98059, a mitogen-activated protein kinase kinase inhibito
r, or antisense oligonucleotide for RA301/Tra2 beta, Consistent with a link
between RA301/Tra2 beta and cell proliferation, platelet-derived growth fa
ctor also induced expression of RA301/Tra2 beta in cultured VSMCs. These da
ta suggest a possible role for RA301/Tra2 beta in the regulation of VSMC pr
oliferation, especially in the setting of hypoxia/reoxygenation-induced cel
l stress.